Jonathan Cotliar - Oct 25, 2021 Form 4 Insider Report for Science 37 Holdings, Inc. (SNCE)

Role
Chief Medical Officer
Signature
/s/ Christine Pellizzari, Attorney-in-Fact for Jonathan Cotliar
Stock symbol
SNCE
Transactions as of
Oct 25, 2021
Transactions value $
$41,434
Form type
4
Date filed
2/25/2022, 03:26 PM
Previous filing
Oct 8, 2021
Next filing
Jan 11, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNCE Common Stock Options Exercise $3.86K +4.54K +0.85% $0.85 540K Oct 25, 2021 Direct
transaction SNCE Common Stock Options Exercise $4.98K +5.86K +1.08% $0.85 546K Oct 25, 2021 Direct
transaction SNCE Common Stock Options Exercise $27.2K +68.1K +12.47% $0.40 614K Oct 28, 2021 Direct
transaction SNCE Common Stock Options Exercise $830 +977 +0.16% $0.85 615K Dec 2, 2021 Direct
transaction SNCE Common Stock Options Exercise $4.54K +11.3K +1.85% $0.40 626K Dec 2, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SNCE Stock Option Options Exercise $0 -4.54K -100% $0.00* 0 Oct 25, 2021 Common Stock 4.54K $0.85 Direct F1
transaction SNCE Stock Option Options Exercise $0 -5.86K -54.54% $0.00 4.88K Oct 25, 2021 Common Stock 5.86K $0.85 Direct F2
transaction SNCE Stock Option Options Exercise $0 -68.1K -23.08% $0.00 227K Oct 28, 2021 Common Stock 68.1K $0.40 Direct F3, F4
transaction SNCE Stock Option Options Exercise $0 -977 -20.01% $0.00 3.91K Dec 2, 2021 Common Stock 977 $0.85 Direct F5
transaction SNCE Stock Option Options Exercise $0 -11.3K -5% $0.00 216K Dec 2, 2021 Common Stock 11.3K $0.40 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock Option was fully vested and exercisable as of the date of the transaction.
F2 Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the vesting date.
F3 Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.
F4 The total amount has been adjusted to add eight derivative securities that were not previously included due to a rounding error.
F5 Stock Option will vest in equal monthly installments until fully vested on March 7, 2022, subject to the executive's continued service through the applicable vesting date.
F6 Stock Option will vest in equal monthly installments until fully vested on June 19, 2023, subject to the executive's continued service through the applicable vesting date.